Seroprevalence of SARS-CoV-2 N antibodies between December 2021 and March 2023 in Japan

Seiya Yamayoshi,Etsuko Nagai,Keiko Mitamura,Masao Hagihara,Ryo Kobayashi,Satoshi Takahashi,Akimichi Shibata,Yoshifumi Uwamino,Naoki Hasegawa,Asef Iqbal,Isamu Kamimaki,Kiyoko Iwatsuki-Horimoto,Tokiko Nagamura-Inoue,Yoshihiro Kawaoka
DOI: https://doi.org/10.1017/s0950268824000141
2024-01-24
Epidemiology and Infection
Abstract://static.cambridge.org/content/id/urn%3Acambridge.org%3Aid%3Aarticle%3AS0950268824000141/resource/name/firstPage-pdf-S0950268824000141a.jpg
infectious diseases,public, environmental & occupational health
What problem does this paper attempt to address?